Acute Pseudogout Flare Management – Evidence‑Based First‑Line Strategies

First‑Line Pharmacologic Options

• NSAIDs, colchicine, and oral corticosteroids are recommended as first‑line agents for acute pseudogout flares, with the choice guided by renal function, cardiovascular risk, and gastrointestinal comorbidities. 1

NSAID Initiation and Dosing

• Full‑dose NSAID therapy should be started within 24 hours of symptom onset to achieve maximal efficacy. 1
• The NSAID dose must be maintained at the full anti‑inflammatory level for the entire duration of the attack and should not be reduced prematurely. 1

Importance of Early Treatment

• Initiating any therapy within the first 24 hours is critical; delaying treatment beyond this window markedly reduces the effectiveness of all agents. 1
• Early treatment (≤24 hours) is a key determinant of successful pain control in acute pseudogout. 1

Contraindicated Combination Therapy

• Concurrent use of NSAIDs with systemic corticosteroids should be avoided because of synergistic gastrointestinal toxicity. 1